Martin D. Madaus, Director at REPLIGEN CORP (RGEN), bought 2,530 shares at $124.54 ($316K) on 2024-06-14, disclosed to the SEC on 2024-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.54 | 915 | $114K | 36.1% |
| 2 | $124.54 | 915 | $114K | 36.1% |
| 3 | $125.46 | 700 | $88K | 27.8% |
| Total | $124.79 avg | 2,530 | $316K | 100% |
| Filing → |
| AZTA | BUY | 2024-11-19 | $403K | — | Filing → |
| RGEN | BUY | 2023-05-08 | $238K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $1.5M | — | Filing → |